Susan E. Nozell

3.4k citations
44 papers · 2.7k indexed · h-index 30
Topics
NF-κB Signaling Pathways (11 papers)Cytokine Signaling Pathways and Interactions (11 papers)interferon and immune responses (6 papers)

In The Last Decade

Susan E. Nozell

44 papers receiving 2.7k citations

Peers

Susan E. Nozell
Comparison fields: 5 of 110
  • Molecular Biology 1.5k
  • Oncology 791
  • Cancer Research 562
  • Immunology 539
  • Genetics 245
Replace Chi Ma with:
Chi Ma United States
Maria Z. Kounnas United States
Rajeshwar R. Tekmal United States
Yoshinori Otsuki Japan
Qi Xie China
Linda M. Boxer United States
Ajay Rana United States
Konstantinos Evangelou Greece
Carmé Caelles Spain
Bangyan L. Stiles United States
Susan E. Nozell relative to Chi Ma United States Chi Ma's profile →
Citations per field
00.5×1.7×
Chi Ma · 1×
Citations per year

Countries citing papers authored by Susan E. Nozell

Since Specialization
Citations

This map shows the geographic impact of Susan E. Nozell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Nozell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Nozell more than expected).

Fields of papers citing papers by Susan E. Nozell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Nozell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Nozell. The network helps show where Susan E. Nozell may publish in the future.

Co-authorship network of co-authors of Susan E. Nozell

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Nozell. A scholar is included among the top collaborators of Susan E. Nozell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Nozell. Susan E. Nozell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 14
3 80
4 15
5 48
6 51
7 4
8 56
9 129
10 32
11 111
12 71
13 40
14 39
15 152
16 64
17 26
18 13
19 42
20 14

About Susan E. Nozell

Susan E. Nozell is a scholar working on Cancer Research, Oncology and Immunology, having authored 44 papers that have together received 2.7k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (11 papers), Cytokine Signaling Pathways and Interactions (11 papers) and interferon and immune responses (6 papers). The work is most often cited by research in Cancer Research (562 citations), Oncology (791 citations) and Immunology (539 citations). Susan E. Nozell has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Etty Benveniste, Suzanne Oparil, Dongqi Xing, Yiu-Fai Chen, Kelly L. Harms, Rajani Rajbhandari, Xinbin Chen, Braden C. McFarland, Fadi G. Hage and G. Kenneth Gray. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026